Genetic Engineering News
Carl Zeiss Meditec, Inc. (CZM) reported that it has received U.S. Food & Drug Administration (FDA) clearance to market the laser keratome applications of its VISUMAX femtosecond laser system. The company had previously projected that this clearance would be granted in the second half of 2007, and the more rapid achievement of this process is an important and welcomed milestone for the company.